TY - JOUR JF - Frontiers in Neurology A1 - Ghazaleh, N A1 - Houghton, R A1 - Palermo, G A1 - Schobel, SA A1 - Wijeratne, PA A1 - Long, JD KW - Science & Technology KW - Life Sciences & Biomedicine KW - Clinical Neurology KW - Neurosciences KW - Neurosciences & Neurology KW - Huntington's disease KW - disease progression KW - prognostic variables KW - machine learning KW - random forest KW - VARIABLE IMPORTANCE KW - PREMANIFEST KW - BIOMARKER KW - ONSET KW - MOTOR KW - HD N2 - Huntington?s disease (HD) is characterised by a triad of cognitive, behavioural, and motor symptoms which lead to functional decline and loss of independence. With potential disease-modifying therapies in development, there is interest in accurately measuring HD progression and characterising prognostic variables to improve efficiency of clinical trials. Using the large, prospective Enroll-HD cohort, we investigated the relative contribution and ranking of potential prognostic variables in patients with manifest HD. A random forest regression model was trained to predict change of clinical outcomes based on the variables, which were ranked based on their contribution to the prediction. The highest-ranked variables included novel predictors of progression?being accompanied at clinical visit, cognitive impairment, age at diagnosis and tetrabenazine or antipsychotics use?in addition to established predictors, cytosine adenine guanine (CAG) repeat length and CAG-age product. The novel prognostic variables improved the ability of the model to predict clinical outcomes and may be candidates for statistical control in HD clinical studies. ID - discovery10129873 UR - http://doi.org/10.3389/fneur.2021.678484 PB - FRONTIERS MEDIA SA N1 - This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ TI - Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's Disease VL - 12 AV - public Y1 - 2021/05/20/ EP - 8 ER -